Search results
Results From The WOW.Com Content Network
AIM ImmunoTech Inc. (NYSE: AIM) shares are trading higher on Tuesday after the company announced the receipt of "statistically significant positive survival results" in pancreatic cancer from an ...
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. [2] Founded in 1990, the company has twenty-three employees.
Shares of thinly-traded microcap AIM ImmunoTech Inc. (NYSE: AIM ) are trading sharply higher after the company announced the Department of Defense granted a four-year, $6.42 million "Breakthrough ...
NYSE American was formerly known as NYSE Market and as the American Stock Exchange and is owned by Intercontinental Exchange. Subcategories This category has only the following subcategory.
Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). [1] There is some evidence it may improve some ME/CFS symptoms. [1] It is an immunomodulatory double-stranded RNA drug similar to the prototypical RNA poly I:C.
For premium support please call: 800-290-4726 more ways to reach us
The biotechnology sector is growing in the New York City area, based upon the region's strength in academic scientific research and public and commercial financial support. By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!